Browsing by Author "Gardiner, Gail J."

Now showing 1 - 4 of 4
  • Thumbnail Image
    Item
    A Role for NADPH Oxidase in Antigen Presentation
    (Frontiers Media, 2013-09-23) Gardiner, Gail J.; Deffit, Sarah N.; McLetchie, Shawna; Pérez, Liliana; Walline, Crystal C.; Blum, Janice S.; Microbiology and Immunology, School of Medicine
    The nicotinamide adenine dinucleotide phosphate (NADPH) oxidase expressed in phagocytes is a multi-subunit enzyme complex that generates superoxide (O2.−). This radical is an important precursor of hydrogen peroxide (H2O2) and other reactive oxygen species needed for microbicidal activity during innate immune responses. Inherited defects in NADPH oxidase give rise to chronic granulomatous disease (CGD), a primary immunodeficiency characterized by recurrent infections and granulomatous inflammation. Interestingly, CGD, CGD carrier status, and oxidase gene polymorphisms have all been associated with autoinflammatory and autoimmune disorders, suggesting a potential role for NADPH oxidase in regulating adaptive immune responses. Here, NADPH oxidase function in antigen processing and presentation is reviewed. NADPH oxidase influences dendritic cell (DC) crosspresentation by major histocompatibility complex class I molecules through regulation of the phagosomal microenvironment, while in B lymphocytes, NADPH oxidase alters epitope selection by major histocompatibility complex class II molecules.
  • Thumbnail Image
    Item
    Hyperactivation of B cells from Immunodeficient Patients
    (Office of the Vice Chancellor for Research, 2013-04-05) McLetchie, Shawna K.; Deffit, Sarah N.; Gardiner, Gail J.
    Chronic granulomatous disease (CGD) is an inherited immunodeficiency associated with defects in NADPH oxidase, an enzyme that produces oxygen radicals necessary to kill bacterial and fungal pathogens. NADPH oxidase, made up of six subunits, is located in endosomal and plasma membranes of immune cells. Although best studied in macrophages and neutrophils, the oxidase is expressed in B cells where we have shown its link to adaptive immunity and antigen presentation. Here, NADPH oxidase function was disrupted by mutations or gene knockdown in human B cells, and the role of the oxidase in innate immunity specifically Toll-like receptor (TLR) signaling tested. TLR7 and 9, which recognize viral single-stranded RNA and unmethylated CpG DNA respectively, potentially share an endosomal compartment with the oxidase in B cells. In this project, B cells were stimulated for 24 hours with TLR7 and 9 ligands along with a costimulator PMA. TLR7 signaling was significantly enhanced in oxidase deficient B cell lines compared with their respective control cells as evidenced by increased IL-6 secretion detected by an ELISA. CGD patients are incapable of producing oxygen radicals rendering them immunodeficient in terms of pathogen infection. Yet these patients also develop many autoimmune disorders associated with hyperactivation of the immune system. Thus, our studies on TLR activation using CGD cell lines may explain in part the development of autoimmunity in individuals with CGD. Additional studies are underway to examine the regulation of TLR including receptor expression levels and the subcellular localization of the NADPH oxidase in these B cells from CGD patients. This work has not yet been published and was supported by NIH 3R01AI079065-03S1.
  • Thumbnail Image
    Item
    ICOS-Expressing Lymphocytes Promote Resolution of CD8-Mediated Lung Injury in a Mouse Model of Lung Rejection
    (Public Library of Science, 2013-08-13) Wu, Qiang; Gardiner, Gail J.; Berry, Elizabeth; Wagner, Sarah R.; Lu, Tiffany; Clay, Bryan S.; Moore, Tamson V.; Ferreira, Caroline M.; Williams, Jesse W.; Luster, Andrew D.; Medoff, Benjamin D.; Cannon, Judy L.; Sperling, Anne I.; Shilling, Rebecca A.; Medicine, School of Medicine
    Acute rejection, a common complication of lung transplantation, may promote obliterative bronchiolitis leading to graft failure in lung transplant recipients. During acute rejection episodes, CD8(+) T cells can contribute to lung epithelial injury but the mechanisms promoting and controlling CD8-mediated injury in the lung are not well understood. To study the mechanisms regulating CD8(+) T cell-mediated lung rejection, we used a transgenic model in which adoptively transferred ovalbumin (OVA)-specific cytotoxic T lymphocytes (CTL) induce lung injury in mice expressing an ovalbumin transgene in the small airway epithelium of the lungs (CC10-OVA mice). The lung pathology is similar to findings in humans with acute lung transplant. In the presence of an intact immune response the inflammation resolves by day 30. Using CC10-OVA.RAG(-/-) mice, we found that CD4(+) T cells and ICOS(+/+) T cells were required for protection against lethal lung injury, while neutrophil depletion was not protective. In addition, CD4(+)Foxp3 (+) ICOS(+) T cells were enriched in the lungs of animals surviving lung injury and ICOS(+/+) Tregs promoted survival in animals that received ICOS(-/-) T cells. Direct comparison of ICOS(-/-) Tregs to ICOS(+/+) Tregs found defects in vitro but no differences in the ability of ICOS(-/-) Tregs to protect from lethal lung injury. These data suggest that ICOS affects Treg development but is not necessarily required for Treg effector function.
  • Thumbnail Image
    Item
    LAMP-2C inhibits MHC class II presentation of cytoplasmic antigens by disrupting chaperone-mediated autophagy
    (American Association of Immunologists, 2016-03-15) Pérez, Liliana; McLetchie, Shawna; Gardiner, Gail J.; Deffit, Sarah N.; Zhou, Delu; Blum, Janice S.; Department of Microbiology & Immunology, IU School of Medicine
    Cells use multiple autophagy pathways to sequester macromolecules, senescent organelles, and pathogens. Several conserved isoforms of the lysosome-associated membrane protein-2 (LAMP-2) regulate these pathways influencing immune recognition and responses. LAMP-2A is required for chaperone-mediated autophagy (CMA), which promotes Ag capture and MHC class II (MHCII) presentation in B cells and signaling in T cells. LAMP-2B regulates lysosome maturation to impact macroautophagy and phagocytosis. Yet, far less is known about LAMP-2C function. Whereas LAMP2A and LAMP2B mRNA were broadly detected in human tissues, LAMP2C expression was more limited. Transcripts for the three LAMP2 isoforms increased with B cell activation, although specific gene induction varied depending on TLR versus BCR engagement. To examine LAMP-2C function in human B cells and specifically its role in Ag presentation, we used ectopic gene expression. Increased LAMP-2C expression in B cells did not alter MHCII expression or invariant chain processing, but did perturb cytoplasmic Ag presentation via CMA. MHCII presentation of epitopes from exogenous and membrane Ags was not affected by LAMP-2C expression in B cells. Similarly, changes in B cell LAMP-2C expression did not impact macroautophagy. The gene expression of other LAMP2 isoforms and proteasome and lysosomal proteases activities were unperturbed by LAMP-2C ectopic expression. LAMP-2C levels modulated the steady-state expression of several cytoplasmic proteins that are targeted for degradation by CMA and diminished peptide translocation via this pathway. Thus, LAMP-2C serves as a natural inhibitor of CMA that can selectively skew MHCII presentation of cytoplasmic Ags.